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Multiple  Hereditary  Osteochondromatosis 
(MHO) is an autosomal dominant developmental 
disorder characterized by the presence of multiple 
osseous  prominences  with  cartilage  caps,  aris-
ing most commonly from the metaphysis of long 
bones.1-6 However, these exostoses have also been 
found on the diaphysis of long bones, on flat bones, 
and/or on vertebrae.1,5,7 Osteochondromas are the 
most common benign osseous tumors.  Sarcoma-
tous changes have been documented to occur in 
approximately 1-5% of affected patients1-5,8 and de-
fective endochondral ossification is likely to be in-
volved in the formation of osteochondrosarcomas. 
Data indicated that most chondrocytes involved in 
the  growth  of  osteochondromas  can  proliferate, 
and that some of them exhibit bone-forming cell 
characteristics.9 
Cervical  spinal  cord  compression  resulting 
from osteochondroma is a rare and extremely se-
rious complication of MHO.7,10 Some symptoms as 
myelopathy  and paralysis may develop. Neurosur-
gical approach should be recommended in order to 
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AbstrAct
Objectives: Common carious lesions owing to vomiting are not widespread in children. In this 
case, we aimed to report an 11-years-old male patient with common carious lesions due to repeated 
vomitings, chewing and eating difficulty and retarded growth with Multiple Hereditary Osteochon-
dromatosis (MHO). 
Case Report: An 11-years-old boy was referred to Department of Pediatric Dentistry in Faculty of 
Dentistry because of eating difficulty owing to common carious lesions. It was seen that the patient 
growth was generally retarded in extra-oral examination. Some exostoses were also present on the 
extremities. It was learned that he was previously diagnosed as MHO in Faculty of Medicine. Nausea 
and vomiting have been commonly occurring after taking of Didronat. Chewing and eating difficulty 
and inadequate nutrition were present because of bad oral hygiene, carious lesions and remained 
roots. Growth was negatively affected by malnutrition and MHO. 
Results: Diet recommendations were given and oral hygiene behaviors were rearranged. Preven-
tive, surgical, restorative and prosthetical dental applications were applied for dental treatments. 
(Eur J Dent 2007;1:183-187)
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achieve a spinal cord decompression, which usu-
ally results in excellent functional recovery7 and it 
usually has a favorable outcome provided surgical 
decompression is performed before major neuro-
logical damage develops.10
Osteochondromas  may  contribute  to  altered 
osseous growth and growth plate of long bones. 
This altered discrepancy of limb-length or angular 
deformities and may lead to decreased range of 
motion, impaired function and possibly to prema-
ture osteoarthritis. Also, local muscle, tendon or 
nerve irritations can cause symptoms of second-
ary pain.1,11-13  
For  local  irritations  and/or  esthetic  reasons, 
corrective or reconstructive surgery and excision 
of the exostosis may be performed.1,12,14,15 Treat-
ment  should  aim  not  only  at  surgical  resection 
of the masses but also at prevention of deformi-
ties.16 But, it was also reported that the risk of an 
abnormal scarring with keloid formation after os-
teochondroma excision in MHO patients after sur-
gery.6 However if a malignancy suspected, com-
plete surgical excision is the preferred treatment.8 
Otherwise, if a spinal cord compression is present, 
patient may get an excellent recovery without neu-
rologic defects after surgery.7
Rarely, multiple osteocartilaginous nodules in 
temporomandibular  joint  space  and  associated 
joint dysfunction because of synovial osteochon-
dromatosis are reported.17-21
In this case report, an 11-years-old male pa-
tient with generalized carious lesions caused by 
vomiting, bad oral hygiene and his chewing and 
eating difficulty, and retarded growth affected by 
inadequate nutrition and MHO are presented. 
cAsE rEPort
An 11-years-old male patient was referred to 
Department  of  Pediatric  Dentistry  of  Faculty  of 
Dentistry due to severe carious lesions and eat-
ing  difficulty.  The  patient  growth  was  generally 
retarded. Some exostoses and shape anomalies 
were present on the extremities and vertebral col-
umn. In anamnesis, his mother reported that, he 
was diagnosed as MHO at early childhood at one of 
Faculty of Medicine. Mother had not got any seri-
ous problem during pregnancy and there was not 
kinship between mother and father. The baby had 
a normal body shape after birth, but the several 
deformities and outgrowth of the bones had begun 
to occur at the age of 2. When the MHO was diag-
nosed, the medical treatment was started immedi-
ately. The patient has been treating with Vitamin D 
(Devit-3 oral drop, 400 IU/day, daily use), Calcium 
(Calcimed  Fort  effervescent  tablet,  500  mg/day, 
daily use) and Etidronate disodium (Didronat-PMO 
tablet, 400 mg/day, to be used in a scheme once a 
day for 15 days following an interruption duration 
of 2.5 months) to prevent from osteoporosis. His 
mother reported that, he had severe gastrointes-
tinal symptoms such as nausea and vomiting with 
every  intaking  periods  of  Didronat.  He  had  also 
more carious lesions. The chewing and eating dif-
ficulties and an inadequate nutrition were present. 
There was a general physical weakness. Growth 
was negatively affected by MHO and malnutrition. 
His height was 124 centimeters and his weight 
was 21 kilograms. The growth of body was seen 
retarded according to other children in the same 
age.  Several  skeletal  deformities  were  present 
on extremities and vertebras. The right and left 
forearms, wrists and shoulders, right shank and 
patella and left side of thorax were affected by dis-
ease (Figures 1 and 2). Mental retardation was not 
present.
Oral hygiene was very poor.  In clinical and ra-
diographical examinations, there were severe car-
ious lesions on 11, 21, 12, 22, 31, 41, 32, 42, 73, 83 
numbered teeth and remained roots were pres-
ent from 74, 75, 36, 46 numbered teeth. 16 and 26 
numbered teeth were not present. It was learned 
that, they were more previously extracted caused 
by severe carious lesions and pain. It was seen 
that, the rotation of the 23, 24 and 25 numbered 
teeth was abnormal in panoramic radiography and 
they were not shown in oral cavity yet. Wide plaque 
layers were present on the surfaces of the teeth 
and roots (Figures 3 and 4). 
An effective tooth-brushing method was shown. 
The oral hygiene behaviours were rearranged. Es-
sential diet recommendations were given and a 
topical fluoride gel was applied. The patient was 
prescribed with a chlorhexidine gluconate solu-
tion to reduce the levels of pathogen microorgan-
isms before dental treatment. All remained roots 
with excessive carious lesions were then extracted 
(74,75,36,46 numbered teeth). 
The carious lesions on 11,21,12,22,31,41,32,42
,73,83 numbered teeth were cleaned with a high 
speed,  water-cooled  dental  torgue  (KaVo  Super July 2007 - Vol.1
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Torque, Germany) and teeth were then restored 
with a composite resin and a total-etch adhesive 
system  (Charisma  composite  resin,  Heraeus-
Kulzer, Germany, Single Bond adhesive system, 
3M,USA). 
A consultation with Department of Orthodon-
tics was made for patient. With two clinical consid-
erations together, to make removable partial den-
tures for providing a sufficient chewing function 
immediately and observation of oral condition with 
frequently dental visits were approved for treat-
ment. Impressions of the both arches were then 
taken, and removable partial dentures were made 
for both dental arches (Figure 5). Regularly dental 
visits were recommended to the patient and ob-
servation of oral condition with frequently dental 
controls were approved for future treatment.
dIscussIon
Osteochondromatosis,  also  known  as  osteo-
cartilaginous exostosis is the most frequent be-
nign bone tumor of the skeletal system.1-5,22 Os-
teochondroma may occur in some short bones and 
may  develope  endochondral  ossification  despite 
its preference for long bones.22 Affected individu-
als exhibit bilateral deformities and multiple os-
teochondromas in the hands, wrists, legs and feet. 
The forearms and wrists are the most common in-
fluenced sites. These deformities include relative 
shortening of the ulna, bowing of the radius, ulnar 
deviation of the distal aspect of the radius, wrist 
and hand.5,11-14 In this case, all these deformities 
and  multiple  osteochondromas  were  present  in 
defined locations. However, rarely reported mul-
Figure 1. The clinical view of the shoulders and left side of the 
thorax. 
Figure 2. The clinical view of the subjacent extremities.  Figure 3.  The intra-oral clinical view of the patient. 
Figure 4. The intra-oral radiographical view of the patient. Figure 5. The intra-oral clinical view of the patient after pros-
thetical dental treatment.
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tiple osteocartilaginous nodules in temporoman-
dibular joint space at Synovial Osteochondroma-
tosis17-20 were not present in our case.
Patil et al23 reported that the males were pre-
dominantly  affected  with  Osteochondromatosis 
such as in our case.
Some  inhibitor  drugs  which  were  called  as 
Bisphosphonates are necessary in the treatment 
of MHO for reducing bone resorption and improve 
the  bone  mineral  density  (BMD).24-26  Bisphos-
phonates are powerful inhibitors of osteoclastic 
activity25 and they are syntheric analogs of inor-
ganic pyrophosphate that have a high affinity for 
calcium.24,25 They are excreted through the kid-
neys without metabolic alteration.25 During bone 
resorption,  they  are  released  from  the  bone 
surface  and  may  be  reincorporated  into  newly 
formed bone or osteclasts.24  So, they can play 
an important role in the treatment of loss of min-
eral density and significantly increase BMD.24,27,28 
Otherwise,  bisphosphonates  can  cause  some 
gastrointestinal system (GIS) reactions, mucosal 
ulcerations, exposed devitalized bone etc.24 They 
led to compromised oral hygiene of the dentition 
and local infections. This impaired oral hygiene, 
in turn, may have facilitated local infection lead-
ing to advanced bone necrosis (osteonecrosis),24,25 
and subsequent increased tooth mobility and loss. 
Past dental history for many of the patients re-
vealed recent tooth extraction.24 
Didronat  (Etidronate  disodium)  which  was 
used medicament in this case is one of drugs of 
Bisphosphonates.29,30  It  increases  the  BMD  and 
bone turnover but may also give rise to some GIS 
symptoms such as diarrhea, nausea, and vomit-
ing30 and/or esophageal lesions such as oesopha-
gitis or oesophageal ulceration.29 Repeating vom-
itings cause to acidic levels of oral pH in oral cavity 
and acidic pH helps to starting and developing of 
the carious lesions on the teeth. If patient does 
not adequately brushes his/her teeth daily, bad 
oral hygiene rapidly boosts this condition. Carious 
lesions cause to loss of the dental structures of 
the teeth. The chewing and eating difficulties may 
occur owing to the structural lost in time. Insuf-
ficient nutrition may affect growth negatively and 
quality of life may also decrease. 
In our case, adverse GIS effects of Didronat 
was also caused to bad oral hygiene and some 
GIS reactions. Therefore, several carious lesions, 
loss of teeth and malnutrition were occurred and 
all these symptoms have been negatively affected 
the growth and life quality of the child. The pre-
ventive and other dental treatments are very im-
portant and necessary to obtain a good oral condi-
tion and sufficient chewing and eating functions. 
The improved nutrition may provide a better life 
quality for the patient. So, necessary dental treat-
ments were made for obtaining these better con-
ditions and patient was also called for regularly 
dental  controls  and  possible  necessary  dental 
treatments in the future. 
concLusIon
In this case report, a male patient in 11-years-
old was presented with common severe carious 
lesions caused by repeated vomitings due to the 
mandatory using of a medicine (Didronat) for MHO 
and also bad oral hygiene. A multidisciplinary den-
tal treatment had applied to get improvements in 
the  oral  and  systemic  conditions  of  the  patient 
near medical treatment.    
AcKnoWLEdGEMEnts 
Patient’s dental treatments were practiced by 
the first and the second authors at Clinic of Pe-
diatric Dentistry in Faculty of Dentistry of Ankara 
University during the PhD educations of authors. 
When preparing the article, it was consulted to the 
medical info of the third author for assessment of 
the prognosis of the disease and the the effects of 
the medicines on disease and body. 
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